Literature DB >> 2112905

Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition.

U Suchner1, M M Rothkopf, G Stanislaus, D H Elwyn, V Kvetan, J Askanazi.   

Abstract

Six severely malnourished patients with chronic obstructive pulmonary disease were maintained for 3 days with infusions of 5% dextrose in water followed by 12 days of eucaloric total parenteral nutrition. On days 8 through 11, they received 30 micrograms/d of growth hormone and twice this amount on days 11 through 15. Growth hormone had no significant effects on the plasma concentration of glucose, cortisol, or glucagon but caused a 50% increase in insulin and a 250% increase in somatomedin C concentrations. A positive nitrogen balance of 2 g/d due to growth hormone was probably mediated by insulin. Growth hormone-induced increases in energy expenditure and fat oxidation and decrease in glucose oxidation cannot be accounted for by insulin. The ability of growth hormone to improve nitrogen balance may be particularly important for malnourished patients with chronic obstructive pulmonary disease who, because of their pulmonary insufficiency, are intolerant of excess nutrients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112905

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Avoiding autocannibalism.

Authors:  R J Ross; J P Miell; C R Buchanan
Journal:  BMJ       Date:  1991-11-09

Review 2.  The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

Authors:  R J Ross; J Rodriguez-Arnao; J Bentham; J H Coakley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 3.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

4.  Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury.

Authors:  W G Cioffi; D C Gore; L W Rue; G Carrougher; H P Guler; W F McManus; B A Pruitt
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

5.  Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis.

Authors:  A Schibler; R von der Heiden; P Birrer; P E Mullis
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

Review 6.  Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?

Authors:  Jean K Berry; Charles Baum
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Trophic factors in aging. Should older people receive hormonal replacement therapy?

Authors:  D T Villareal; J E Morley
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.